NCT04746469: FIT

Using Behavioral Science to Improve Colorectal Cancer Screening Rates With Mailed FIT Kits

Completed NA Last updated 13 September 2022

What this trial tests

NA trial testing Delayed automated phone call in Colorectal Cancer Screening in 2,500 participants. Completed in 1 August 2022.

Timeline

2 September 2020

Primary endpoint
1 August 2022

1 August 2022

Quick facts

Lead sponsor	University of California, Los Angeles
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	2,500
Start date	2 September 2020
Primary completion	1 August 2022
Estimated completion	1 August 2022
Sites	1 location across United States

Drugs / interventions tested

• Delayed automated phone call

Conditions studied

• Colorectal Cancer Screening — all drugs for Colorectal Cancer Screening →

Sponsor

University of California, Los Angeles

Who can join

Adults 50 to 75, any sex, with Colorectal Cancer Screening. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

As a part of UCLA Health's continued goal of improving patient care the investigators are updating our mailing campaign for our FIT Kit colorectal cancer screening that the investigators administer 2 times per year to include an automated phone call reminder to patients who are overdue for average-risk colorectal cancer screening and enrolled in a mailed FIT program. This will help the investigators evaluate if automated phone calls are effective at improving compliance with CRC screening, in addition to mailed FIT and embedded electronic health record (EHR) portal messages to patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Current Progress in Clinical Research in Secondary Prevention and Early Detection of Colorectal Cancer.
   Partyka O, Pajewska M, Czerw A, Deptała A, et al · · 2025 · cited 2× · PMID 39941735 · DOI 10.3390/cancers17030367